Average body weight trends for the four groups during the post-challenge period. by Oumayma Arbani (21001472)

Subjects:

Effect of PRP on spermatozoa ROS production as assessed by the NBT test. by Rim Kooli (15426816)

Subjects:

Amplification of <i>DpAP2</i> full-length cDNA. by Lingru Ruan (18995544)

Subjects:

Verification of transgenic <i>D</i>. <i>parva</i>. by Lingru Ruan (18995544)

Subjects:

Effect of PRP on succinate dehydrogenase activity as assessed by the MTT test. by Rim Kooli (15426816)

Subjects:

Line chart of NBT absorbance after PRP supplementation. by Rim Kooli (15426816)

Subjects:

Concentration of active substances found in pollen, nectar or honey and concentration used in the study. by Agnieszka Murawska (11021928)

Subjects:

Raw data underlying the quantitative results reported in the manuscript. by Lai Jiang (2401513)

Subjects:

Trends of average respiratory symptom scores during the post-challenge period. by Oumayma Arbani (21001472)

Subjects:

Construction of transgenic <i>D</i>. <i>parva</i> overexpressing <i>DpAP2</i> gene. by Lingru Ruan (18995544)

Subjects:

Carotenoid contents of control and transgenic <i>D</i>. <i>parva</i>. by Lingru Ruan (18995544)

Subjects:

<i>Leptospira interrogans</i> from Okinawa induces epithelial barrier disruption with different kinetics. by Tetsuya Kakita (4922584)

Renal outcomes of both treatment groups. by Marwan El-Deyarbi (21688492)

“…</p><p>Conclusions</p><p>Implementing multifactorial interventions by a multidisciplinary team improved several clinical manifestations, including HbA1c, SBP, and eGFR, and decreased cardiovascular risk factors despite the decreased diabetes medication use.…”

Age-adjusted incidence rate of gastric cancer over 2000–2019 and in 2020 in the United States, by histologic type. by Armin Aslani (13009188)

Subjects:

Percent change in age-standardized and delay-adjusted incidence rates of gastric cancer from 2019 to 2020, by age, race and sex in the United States, using the November 2022 data s... by Armin Aslani (13009188)

Subjects:

Counts and age-standardized rate of carcinoid tumor incidence per 100,000 and average annual percent change from 2000 to 2019 in the United States, by age, sex, and race. by Armin Aslani (13009188)

Subjects:

Counts and age-standardized rate of gastric cancer incidence per 100,000 and average annual percent change from 2000 to 2019 in the United States, by age, sex, and race. by Armin Aslani (13009188)

Subjects:

Counts and age-standardized rate of gastric adenocarcinoma incidence per 100,000 and average annual percent change from 2000 to 2019 in the United States, by age, sex, and race. by Armin Aslani (13009188)

Subjects:

Counts and age-standardized rate of signet ring carcinoma incidence per 100,000 and average annual percent change from 2000 to 2019 in the United States, by age, sex, and race. by Armin Aslani (13009188)

Subjects:

Counts and age-standardized rate of gastrointestinal stromal tumor incidence per 100,000 and average annual percent change from 2000 to 2019 in the United States, by age, sex, and... by Armin Aslani (13009188)

Subjects: